Cargando…
Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy
BACKGROUND: Erythropoiesis stimulating agents (ESAs) are widely used to treat anaemia but concerns exist about their potential to promote pathological angiogenesis in some clinical scenarios. In the current study we have assessed the angiogenic potential of three ESAs; epoetin delta, darbepoetin alf...
Autores principales: | McVicar, Carmel M., Colhoun, Liza M., Abrahams, Jodie L., Kitson, Claire L., Hamilton, Ross, Medina, Reinhold J., Durga, Dash, Gardiner, Tom A., Rudd, Pauline M., Stitt, Alan W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912370/ https://www.ncbi.nlm.nih.gov/pubmed/20686695 http://dx.doi.org/10.1371/journal.pone.0011870 |
Ejemplares similares
-
Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
por: McVicar, Carmel M., et al.
Publicado: (2011) -
RAGE Regulates Immune Cell Infiltration and Angiogenesis in Choroidal Neovascularization
por: Chen, Mei, et al.
Publicado: (2014) -
The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies
por: Medina, Reinhold J., et al.
Publicado: (2008) -
MicroRNA‐containing extracellular vesicles released from endothelial colony‐forming cells modulate angiogenesis during ischaemic retinopathy
por: Dellett, Margaret, et al.
Publicado: (2017) -
Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
por: McVicar, Carmel M., et al.
Publicado: (2015)